MSB 5.24% $1.11 mesoblast limited

Our CEO emphasized that NVS interest in REM-L is focused on the...

  1. Yor
    150 Posts.
    lightbulb Created with Sketch. 70
    Our CEO emphasized that NVS interest in REM-L is focused on the treatment ARDS -a huge addressable market- regardless of whether induced by C-19 or not.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.